2006 -2007 Project Team Lead, Neuroscience Medicinal Chemistry @
2004 -2006 Senior Principal Scientist, CNS Medicinal Chemistry @
2001 -2004 Senior Research Scientist, CNS Medicinal Chemistry @
1999 -2001 Research Scientist, CNS Medicinal Chemistry @
2022 -now Member Board Of Directors @
2022 -now Technical Advisory Board @
2022 -now Member Board of Directors @
2021 -now Board Observer @
2021 -now Board of Directors @
2019 -now Board Of Directors @
2021 -now Board of Directors @
2018 -2021 Board observer @
2019 -2025 Board Of Directors @
2019 -2024 Board Of Directors @ Adapsyn Biosciences
2021 -2021 Member Board Of Directors @ Pyxis Oncology
2019 -2020 Board Observer @
2019 -2020 Board Of Directors @
2018 -2019 Board Observer @
2019 -2020 Board Observer @ Petra Pharma Corporation
2018 -2019 Board Observer @
Chris O'Donnell Education
UC Irvine
Post Doc (Organic Chemistry)
University of Wisconsin-Madison
PhD (Organic Chemistry)
University of Illinois at Urbana-Champaign
Bachelor of Science - BS (Organic Chemistry)
Chris O'Donnell Summary
Chris O'Donnell, based in United States, is currently a Vice President - Business Development and Partner, Pfizer Ventures at Pfizer. Chris O'Donnell brings experience from previous roles at Cartography Biosciences, TRexBio, Enlaza Therapeutics and Arrakis Therapeutics. Chris O'Donnell holds a Post Doc in Organic Chemistry @ UC Irvine. Chris O'Donnell has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Chris O'Donnell?
Find contact details for 700 million professionals.